Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

33.6K
Overview
33.6K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

109
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phosphorylation of SNAP-25 at Ser187 is enhanced following its cleavage by Botulinum Neurotoxin Serotype A, promoting the dominant-negative effect of the resulting fragment.

PLoS pathogens·2025
Same author

A Randomized, Blinded, Vehicle-Controlled Dose-Ranging Study to Evaluate and Characterize Remdesivir Efficacy Against Ebola Virus in Rhesus Macaques.

Viruses·2025
Same author

Marburg Virus Medical Countermeasures.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both <i>in vitro</i> and <i>in vivo</i> models.

mSphere·2024
Same author

High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization.

Microorganisms·2024
Same author

HSP90 is part of a protein complex with the L polymerase of Rift Valley fever phlebovirus and prevents its degradation by the proteasome during the viral genome replication/transcription stage.

Frontiers in cellular and infection microbiology·2024

Related Experiment Video

Updated: Mar 10, 2026

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.8K

Will There Be a Cure for Ebola?

Anthony P Cardile1, Travis K Warren1, Karen A Martins1

  • 1US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702;

Annual Review of Pharmacology and Toxicology
|December 14, 2016
PubMed
Summary
This summary is machine-generated.

Despite the 2014 West Africa Ebola outbreak, no Ebola medical countermeasures were approved. This review examines Ebola therapeutics progress and lessons learned for future high-risk pathogen research.

Keywords:
BCX4430GS-5734ZMappbrincidofovirconvalescent plasmafavipiravir

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Related Experiment Videos

Last Updated: Mar 10, 2026

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples
06:59

Rapid, Safe, and Simple Manual Bedside Nucleic Acid Extraction for the Detection of Virus in Whole Blood Samples

Published on: June 30, 2018

7.8K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.7K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Area of Science:

  • Infectious Diseases
  • Virology
  • Clinical Research

Background:

  • The 2014 West Africa Ebola virus outbreak highlighted challenges in developing medical countermeasures.
  • No Ebola therapeutics received US Food and Drug Administration approval despite extensive efforts.

Purpose of the Study:

  • To review the progress of Ebola therapeutics development following the West Africa outbreak.
  • To identify lessons learned for conducting clinical research in resource-poor, high-risk settings.

Main Methods:

  • Review of numerous therapeutics explored or developed during the outbreak.
  • Categorization of therapeutics including repurposed drugs, nucleoside/nucleotide analogues, nucleic acid-based drugs, and immunotherapeutics.

Main Results:

  • Multiple therapeutic candidates were investigated, including BCX4430, brincidofovir, favipiravir, GS-5734, TKM-Ebola, AVI-7537, convalescent plasma, and ZMapp.
  • Valuable insights were gained regarding clinical trial conduct in challenging environments.

Conclusions:

  • The Ebola outbreak provided critical lessons for future pandemic preparedness and therapeutic development.
  • Further research and strategic planning are essential to advance Ebola medical countermeasures.